Clearside Biomedical Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Clearside Biomedical

Access the complete profile.

Clearside Biomedical Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325412 Pharmaceutical Preparation Manufacturing
Address	900 North Point Parkway Suite 200 Alpharetta, 2Q 30005

Note: Revenues for privately held companies are statistical evaluations.


Clearside Biomedical's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Clearside Biomedical's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Clearside Biomedical is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.

Clearside Biomedical Annual Revenue and Growth Rate

Clearside Biomedical	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Clearside Biomedical's revenues are gauged from an analysis of company filings.

Clearside Biomedical's Income Statement (based on Industry Averages)

Clearside Biomedical P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Clearside Biomedical is developing and marketing. Clearside Biomedical doesn't have any recent trademark applications, indicating Clearside Biomedical is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
XIPERE Ocular pharmaceuticals; ophthalmic preparations	04/27/2018
SCS MICROINJECTOR Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; Drug delivery systems	01/18/2017
SUPRATA Ocular pharmaceuticals; Ophthalmic preparations	12/16/2015

See all trademarks and details in the Full Report.

Market Share of Clearside Biomedical's Largest Competitors

A competitive analysis shows these companies are in the same general field as Clearside Biomedical, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MERIDIAN MEDICAL TECHNOLOGIES	Columbia, MD	100
SYNTRON BIORESEARCH	Carlsbad, CA	55
RLS USA	Lake Zurich, IL	49
ALORA PHARMACEUTICALS	Alpharetta, GA	42
LANTHEUS HOLDINGS	North Billerica, MA	33
BROADVIEW INVESTMENTS	Royston, GA	32
RESULTS RNA	Orem, UT	29
CIVICA	Lehi, UT	28
HARMONY BIOSCIENCES	Plymouth Meeting, PA	24

Nearby Competitors

These companies are similar in business line and location to Clearside Biomedical. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
UCB	Smyrna, GA	100
IMMUCOR	Norcross, GA	39
ACELLA PHARMACEUTICALS & AVION PHARMACEUTICALS	Alpharetta, GA	27
ALORA PHARMACEUTICALS	Alpharetta, GA	21
SEBELA PHARMACEUTICALS	Roswell, GA	12
CLEARSIDE BIOMEDICAL	Alpharetta, 2Q	2

Future Competition: Clearside Biomedical's Fastest Growing Competitors

These companies are in the same general field as Clearside Biomedical and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)